• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: GENZYME BIOSURGERY (RIDGEFIELD) SYNVISC ONE; INTRA-ARTICULAR HYALURONIC ACID

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

GENZYME BIOSURGERY (RIDGEFIELD) SYNVISC ONE; INTRA-ARTICULAR HYALURONIC ACID Back to Search Results
Lot Number 7F553A
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Arthralgia (2355); Joint Disorder (2373); Reaction, Injection Site (2442)
Event Date 12/01/2017
Event Type  Injury  
Event Description
This case is cross referred with the case (b)(4) (cluster).This unsolicited case from united states was received on 07-dec-2017 from an other non- health care professional.This case concerns a (b)(6) years old patient (gender: not provided) who received treatment with synvisc one injection and after few days had red knee, hot knee, knee pain and knee aspiration.No medical history, past drug, concomitant medication and concurrent condition was provided.On (b)(6) 2017, patient received treatment with intraarticular synvisc one bilateral injection, at a dose of 6 ml once (batch/lot number: 7f553a and expiration date: 07-dec-2018) for bilateral knee pain.It was reported that only one knee received the held product.Patient came on (b)(6) 2017 with the knee injected with the held product red, hot and pain rated as a 10, on a scale of 1-10, 10 being excruciating (onset date: (b)(6) 2017 and latency: few days).The patient also had knee effusion on an unknown date in (b)(6) 2017.Patient was treated by aspiration and steroid.Corrective treatment: aspiration and steroid for all events outcome: unknown for all events a pharmaceutical technical complaint (ptc) was initiated and results were pending for the same.Seriousness criteria: required intervention for all events.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
SYNVISC ONE
Type of Device
INTRA-ARTICULAR HYALURONIC ACID
Manufacturer (Section D)
GENZYME BIOSURGERY (RIDGEFIELD)
1125 pleadantview terrace
ridgefield NJ 07657
Manufacturer Contact
heather schiappacasse
55 corporate drive
55b-220a
bridgewater, NJ 08807
9089817289
MDR Report Key7156221
MDR Text Key96112382
Report Number2246315-2017-00282
Device Sequence Number1
Product Code MOZ
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
P940015
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type consumer
Reporter Occupation Other
Type of Report Initial
Report Date 12/07/2017
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Other
Device Expiration Date12/07/2018
Device Lot Number7F553A
Is the Reporter a Health Professional? No
Was the Report Sent to FDA? No
Initial Date Manufacturer Received 12/07/2017
Initial Date FDA Received12/30/2017
Is the Device Single Use? Yes
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age50 YR
-
-